| • |
New Revenue Stream for your Practice - Dispensing prepackaged Unit-of-use drug products directly to your patients is a well established process that can generate from $25 to $150 thousand dollars in new revenue utilizing your current patient base. In office dispensing is extremely cost efficient, requires virtually no additional staff time.
|
| • |
Reduction in error rates - Potentially fatal error rates (wrong drug, wrong strength or wrong dosage) in retail pharmacies are approaching 5% in some cases. Cross-contamination in pharmacies is virtually 100%. Incorporating DSI's unit-of-use products to your patients reduces the likely hood of these serious pharmacy related errors.
|
| • |
Reduction in direct labor - Unit-of-use products are prepackaged, labeled and ready for immediate dispensing to the patient. The entire dispensing process can be completed in less than 30 seconds.
|
| • |
Improvement in product quality - The purity and safety of repackaged drug products are directly proportional to the quality control standards utilized by the re-packager. DSI is registered with the FDA, the Food and Drug Branch of the California Health and Human Services Department and with the DEA. DSI maintains the most comprehensive quality control program in the repackaged drug industry. DSI's production process requires seven different employees performing over 120 documented steps to validate the accuracy of every production batch. Every tablet/capsule, bottle, cap and label is 100 percent traceable. No other company provides this level of quality and product safety.
|
